Diker Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,084,317
| Closed | -$86.6M | – | 44 |
|
|
2021
Q1 | $86.6M | Hold |
1,084,317
| – | – | 40.6% | 1 |
|
|
2020
Q4 | $85.5M | Buy |
1,084,317
+56,022
| +5% | +$3.29M | 43.23% | 1 |
|
|
2020
Q3 | $45.2M | Sell |
1,028,295
-7,494
| -0.7% | -$369K | 28.17% | 1 |
|
|
2020
Q2 | $45.8M | Sell |
1,035,789
-128,454
| -11% | -$4.79M | 33.25% | 1 |
|
|
2020
Q1 | $41.8M | Hold |
1,164,243
| – | – | 17.65% | 1 |
|
|
2019
Q4 | $82.5M | Sell |
1,164,243
-2,000
| -0.2% | -$145K | 53.42% | 1 |
|
|
2019
Q3 | $87.2M | Hold |
1,166,243
| – | – | 56.9% | 1 |
|
|
2019
Q2 | $94M | Sell |
1,166,243
-15,200
| -1% | -$1.07M | 39.19% | 1 |
|
|
2019
Q1 | $79M | Sell |
1,181,443
-196,173
| -14% | -$14.9M | 48.17% | 1 |
|
|
2018
Q4 | $103M | Sell |
1,377,616
-5,709
| -0.4% | -$471K | 43.13% | 1 |
|
|
2018
Q3 | $127M | Hold |
1,383,325
| – | – | 45.25% | 1 |
|
|
2018
Q2 | $136M | Sell |
1,383,325
-4,300
| -0.3% | -$481K | 48.67% | 1 |
|
|
2018
Q1 | $155M | Sell |
1,387,625
-18,000
| -1% | -$2.02M | 51.83% | 1 |
|
|
2017
Q4 | $145M | Sell |
1,405,625
-27,740
| -2% | -$2.76M | 51.99% | 1 |
|
|
2017
Q3 | $135M | Sell |
1,433,365
-1,000
| -0.1% | -$78.9K | 54.34% | 1 |
|
|
2017
Q2 | $112M | Sell |
1,434,365
-9,550
| -0.7% | -$717K | 49.6% | 1 |
|
|
2017
Q1 | $116M | Sell |
1,443,915
-344,342
| -19% | -$27.4M | 53.48% | 1 |
|
|
2016
Q4 | $141M | Sell |
1,788,257
-52,670
| -3% | -$4.09M | 59.99% | 1 |
|
|
2016
Q3 | $144M | Hold |
1,840,927
| – | – | 51.17% | 1 |
|
|
2016
Q2 | $127M | Sell |
1,840,927
-3,836
| -0.2% | -$265K | 49.27% | 1 |
|
|
2016
Q1 | $132M | Sell |
1,844,763
-162,000
| -8% | -$10.2M | 50.04% | 1 |
|
|
2015
Q4 | $125M | Sell |
2,006,763
-20,060
| -1% | -$1.22M | 34.82% | 1 |
|
|
2015
Q3 | $115M | Sell |
2,026,823
-19,148
| -0.9% | -$1.01M | 25.36% | 1 |
|
|
2015
Q2 | $110M | Sell |
2,045,971
-12,999
| -0.6% | -$632K | 19.24% | 1 |
|
|
2015
Q1 | $97.8M | Sell |
2,058,970
-511,582
| -20% | -$22.6M | 17.68% | 1 |
|
|
2014
Q4 | $111M | Sell |
2,570,552
-35,499
| -1% | -$1.45M | 21.69% | 1 |
|
|
2014
Q3 | $89.6M | Buy |
2,606,051
+5,980
| +0.2% | +$211K | 17.38% | 1 |
|
|
2014
Q2 | $95.2M | Sell |
2,600,071
-20,176
| -0.8% | -$684K | 20.83% | 1 |
|
|
2014
Q1 | $88.4M | Sell |
2,620,247
-9,632
| -0.4% | -$318K | 19.19% | 1 |
|
|
2013
Q4 | $89.2M | Sell |
2,629,879
-56,622
| -2% | -$1.96M | 20.52% | 1 |
|
|
2013
Q3 | $85.6M | Sell |
2,686,501
-21,374
| -0.8% | -$568K | 21.8% | 1 |
|
|
2013
Q2 | $61.1M | Buy |
+2,707,875
| New | +$58.6M | 18.9% | 1 |
|
Diker Management's CMD Position: Q2 2021 in Review
Diker Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,084,317 shares — an estimated $86.6M sold.
Diker Management first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $155M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Diker Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Diker Management sold 1,084,317 Cantel Medical Corporation shares in Q2 2021, an estimated $86.6M.
- Diker Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Diker Management's Cantel Medical Corporation position peaked at $155M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Diker Management's 13F filing for Q2 2021, filed 16 Aug 2021.